VitalTrace has had the pleasure of participating in iPREP WA's Industry and PhD Research and Engagement Program. We were fortunate to work with our very own “Dream Team”; Alvin Lee, Saman Akbar Zadeh and Georgios Mavropalias, bringing their expertise in signal processing, data science and biomedical science respectively.
Related news

$2.85M successful CRC-P grant win for VitalTrace
VitalTrace and our associated partners are honoured to announce that our CRC-P bid has been successfully awarded a $2.85M grant from the Commonwealth.
VitalTrace and our associated partners are honoured to announce that our CRC-P bid has been successfully awarded a $2.85M grant from the Commonwealth. This grant highlights the importance of improving the standard of care delivered to mothers and babies during the childbirth process, and will fund integral research and development milestones.
We are excited by the opportunity this funding presents to improve the future of childbirth monitoring, with a total project value of $11.3M and a world class team of researchers and innovators.
Thank you to our key supporters to date and everyone that supported this successful bid, particularly Danica Sekulovska GAICD and McGarry House.
CRC-Ps strengthen links between research organisations and industry, to develop new technologies, products, processes and services. For more information, and to see the list of successful projects, visit business.gov.au/crc-p

VitalTrace has commenced the TMCi Accelerator in Texas
VitalTrace participation in TMCi’s (Texas Medical Center Innovation) 2025 HealthTech Accelerator Cohort has begun.
VitalTrace has officially commenced its participation in the Texas Medical Center Innovation (TMCi) 2025 HealthTech Accelerator. Out of over 120 global applicants, we are proud to be one of just 12 companies selected—and among a very small number of international participants.
TMC is the largest healthcare provider in the United States and one of the largest globally. This opportunity has already yielded significant gains for the company, deepening our understanding of the U.S. hospital landscape. Discussions with leading institutions highlighted a consistent drive to reduce caesarean section rates, driven by strong fiscal and clinical imperatives.
Obstetricians and healthcare executives were candid in their support, emphasizing the urgent need for improved diagnostic tools. They shared that legal settlements related to hypoxic-ischemic encephalopathy can exceed US$40 million in Texas—and even higher in states like Massachusetts—underscoring the critical importance of innovation in this space.
We are immensely proud of the team’s efforts in preparing the company for this milestone, and we are deeply encouraged by the warm and validating reception we received in the U.S. We look forward to continuing our participation and contributing meaningfully to the program.

VitalTrace awarded $500,000 by the Future Health Research and Innovation (FHRI) Fund
VitalTrace is proud to announce it is one of 9 WA innovators and start ups to have received support from the Western Australian government, under the Future Health Research and Innovation (FHRI) Fund.
VitalTrace is proud to announce it is one of 9 WA innovators and start ups to have received support from the Western Australian government, under the Future Health Research and Innovation (FHRI) Fund.
The Innovation Seed Fund is intended to bridge the gap in access to early-stage funding for WA start-ups to be more competitive in securing follow-on funding and develop into sustainable businesses, create high-level health sector jobs and enhance the production/manufacturing capacity of WA.
This project will fund the development of a commercialisation ready and clinically compatible product to improve maternal and fetal health outcomes during childbirth.
Medical Research Minister Stephen Dawson said “[VitalTrace has] the potential to change lives, and this funding will help them secure capital and develop into sustainable businesses.”
